Cultured AFB Antitubercular DST Rapid 19 Drugs Panel Test sale cost 5500 AED
SARS-CoV-2 Respiratory Comprehensive Panel Test sale cost 4910 AED SARS-CoV-2 Respiratory Comprehensive Panel Test 5,460 د.إ 4,910 د.إ
Sale!

Cultured AFB Antitubercular DST Rapid 19 Drugs Panel Test

5,500 د.إ

-10%

The Cultured AFB Antitubercular DST Rapid 19 Drugs Panel Test is an advanced diagnostic procedure offered by DNA Labs UAE, designed to swiftly identify the drug susceptibility of Mycobacterium tuberculosis, the bacterium responsible for tuberculosis (TB). Priced at 5500 AED, this comprehensive test covers a panel of 19 drugs, providing critical information on the resistance patterns of the tuberculosis bacteria. This enables healthcare providers to tailor the most effective treatment plans for patients, significantly improving the chances of successful outcomes. The test involves culturing the bacteria from a patient’s sample to evaluate how it responds to the various drugs, ensuring precise and targeted therapy in combating TB. By incorporating this test, DNA Labs UAE plays a pivotal role in the fight against tuberculosis, especially in cases where drug-resistant TB is a concern.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

CULTURED AFB ANTITUBERCULAR DST RAPID 19 DRUGS PANEL Test

Test Name: CULTURED AFB ANTITUBERCULAR DST RAPID 19 DRUGS PANEL Test

Components:

  • Streptomycin
  • Isoniazid
  • Rifampicin
  • Ethambutol
  • Pyrazinamide
  • Clofazimine
  • Ethionamide
  • Capreomycin
  • Kanamycin
  • Amikacin
  • Ofloxacin
  • PAS
  • Cycloserine
  • Levofloxacin
  • Moxifloxacin
  • Linezolid
  • Rifabutin
  • Amoxyclav
  • Clarithromycin

Price: 5500.0 AED

Sample Condition: Submit pure growth of Mycobacterium tuberculosis complex on appropriate media in sterile screw capped container in a sealed plastic bag. Ship refrigerated OR when used with other AFB culture or Mycobacteria identification tests, the pure growth obtained in the Laboratory from specimens already submitted will be processed for Antitubercular Sensitivity.

Report Delivery: Sample Daily by 3.30 pm; Report 21 days

Method: Automated Fluorescent

Test type: Tuberculosis

Doctor: Physician

Test Department:

Pre Test Information: No special preparation required

Test Details

The Cultured AFB Antitubercular DST Rapid 19 Drugs Panel test is a diagnostic test used to determine the susceptibility of Mycobacterium tuberculosis to various drugs. It is a rapid test that can identify the presence of drug-resistant strains of tuberculosis in a culture sample. The test screens for resistance to 19 different antitubercular drugs, including rifampicin, isoniazid, and streptomycin. This information helps healthcare providers choose the most effective treatment for patients with tuberculosis. The test is typically performed on a sputum sample or other bodily fluid that contains the bacteria.

Test Name CULTURED AFB ANTITUBERCULAR DST RAPID 19 DRUGS PANEL Test
Components *Streptomycin*Isoniazid*Rifampicin *Ethambutol*Pyrazinamide *Clofazimine *Ethionamide*Capreomycin*Kanamycin *Amikacin*Ofloxacin*PAS *Cycloserine *Levofloxacin*Moxifloxacin*Linezolid*Rifabutin*Amoxyclav*Clarithromycin
Price 5500.0 AED
Sample Condition Submit pure growth ofMycobacterium tuberculosis complexon appropriate media in sterile screw capped container in a sealed plastic bag. Ship refrigerated ORwhen used with other AFB culture or Mycobacteria identification tests, the pure growth obtained in the Laboratory from specimens already submittedwill be processed for Antitubercular Sensitivity.
Report Delivery Sample Daily by 3.30 pm; Report 21 days
Method Automated Fluorescent
Test type Tuberculosis
Doctor Physician,
Test Department:
Pre Test Information No special preparation required
Test Details

The Cultured AFB Antitubercular DST Rapid 19 Drugs Panel test is a diagnostic test used to determine the susceptibility of Mycobacterium tuberculosis to various drugs. It is a rapid test that can identify the presence of drug-resistant strains of tuberculosis in a culture sample. The test screens for resistance to 19 different antitubercular drugs, including rifampicin, isoniazid, and streptomycin. This information helps healthcare providers choose the most effective treatment for patients with tuberculosis. The test is typically performed on a sputum sample or other bodily fluid that contains the bacteria.

SKU: TEST-832 Category:

Related products